Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion

被引：0
作者：
Gesine B. Jaissle
Peter Szurman
Nicolas Feltgen
Bernhard Spitzer
Amelie Pielen
Matus Rehak
Georg Spital
Heinrich Heimann
Carsten H. Meyer
机构：
[1] University Eye Clinic Tuebingen,Department of Neurology and Bernstein Center for Computational Neuroscience
[2] Centre for Ophthalmology,Department of Ophthalmology
[3] University Eye Hospital Freiburg,St. Paul’s Eye Unit
[4] University Eye Hospital,Department of Ophthalmology
[5] University of Goettingen,undefined
[6] Charité University Hospital,undefined
[7] University Eye Hospital,undefined
[8] University of Leipzig,undefined
[9] St. Franziskus Hospital,undefined
[10] Royal Liverpool University Hospital,undefined
[11] University of Bonn,undefined
[12] University Eye Clinic,undefined
[13] Centre for Ophthalmology,undefined
[14] Eberhard-Karls University of Tuebingen,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2011年 / 249卷
关键词：
Macular edema; Bevacizumab; Branch retinal vein occlusion; Intravitreal therapy; Predictive factors; Prognostic facotrs for visual improvement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：183 / 192
页数：9
相关论文
共 126 条
[11]  
Bynoe LA(2007)Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion Retina 27 419-425
[12]  
Noma H(2008)Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion Ophthalmologica 223 124-127
[13]  
Funatsu H(2009)Intravitreal bevacizumab (Avastin) for macular edema secondary to retinal vein occlusion - twelve-month results of a prospective clinical trial Br J Ophthalmol 93 452-526
[14]  
Yamasaki M(2009)One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 247 27-33
[15]  
Tsukamoto H(2008)Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion Br J Ophthalmol 92 351-355
[16]  
Mimura T(2008)Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study Br J Ophthalmol 92 518-522
[17]  
Sone T(2007)Bevacizumab in retinal vein occlusion—results of a prospective case series Graefes Arch Clin Exp Ophthalmol 245 1429-1436
[18]  
Hirayama T(2009)Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12 months and multiple regression analysis Retina 29 1242-1248
[19]  
Tamura H(2005)Recommendation for the procedure of intravitreal injections of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA) Klin Monatsbl Augenheilkd 222 390-395
[20]  
Yamashita H(2006)Errors in retinal thickness measurements obtained by optical coherence tomography Ophthalmology 113 285-293
12345678910